Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study
ConclusionThe expression characteristics of claudin 18.2 in NENs were characterized, which may provide a clinicopathological reference for targeted therapies in patients with NENs.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Endocrinology | Gastric (Stomach) Cancer | Gastroenterology | Neurology | Pancreas | Study